Bio Solution (086820) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, Bio Solution (086820) reported revenue of 15.2 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202515.2 billion KRW-4.3 billion KRW273 million KRW[source]
202412.9 billion KRW-5.1 billion KRW-11.9 billion KRW[source]
202312.5 billion KRW-5.1 billion KRW-1.4 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202568.5 billion KRW36.5 billion KRW32.0 billion KRW[source]
202467.5 billion KRW36.2 billion KRW31.3 billion KRW[source]
202392.4 billion KRW50.2 billion KRW42.2 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice